XM اپنی سروسز امریکہ کے شہریوں کو فراہم نہیں کرتا ہے۔

U.S. Costco Wholesale, McKesson, Starbucks



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>CORRECTED-U.S. RESEARCH ROUNDUP-Costco Wholesale, McKesson, Starbucks</title></head><body>

Corrects named item code to RCH/US from RCH/EUROPE, the same error was there in a previous version of the U.S. research roundup

Sept 24 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Costco Wholesale, McKesson and Starbucks, on Tuesday.


HIGHLIGHTS


* Costco Wholesale Corp COST.O: Raymond James raises target price to $980 from $880

* First Citizens Bancshares FCNCA.O: Wedbush cuts to neutral from outperform

* McKesson Corp MCK.N: Baird cuts target price to $531 from $603

* Regeneron Pharmaceuticals Inc REGN.O: Leerink Partners cuts target price to $1,077 from $1,175

* Starbucks SBUX.O: Jefferies cuts to underperform from hold

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.


* Acuity Brands Inc AYI.N: Wells Fargo raises target price to $289 from $260

* Affirm Holdings, Inc. AFRM.O: Barclays raises target price to $54 from $50

* Apellis Pharmaceuticals Inc APLS.O: Wells Fargo cuts target price to $43 from $47

* Axos Financial Inc AX.N: Wedbush cuts target price to $75 from $80

* Banc of California Inc BANC.N: Wedbush raises target price to $18 from $14

* Banc of California Inc BANC.N: Wedbush raises to outperform from neutral

* Bankunited Inc BKU.N: Wedbush raises target price to $40 from $39

* Biohaven Ltd BHVN.N: Bernstein raises target price to $66 from $55

* Biohaven Ltd BHVN.N: RBC raises target price to $68 from $59

* Black Diamond Therapeutics BDTX.O: Piper Sandler raises target price to $15 from $12

* Black Diamond Therapeutics Inc BDTX.O: Stifel raises target price to $18 from $15

* BP BP.N: Jefferies cuts target price to $40.1 from $43.8

* Braze Inc BRZE.O: Canaccord Genuity cuts target price to $45 from $53

* Braze Inc BRZE.O: D.A. Davidson cuts target price to $55 from $65

* Braze Inc BRZE.O: Oppenheimer cuts target price to $51 from $60

* Braze Inc BRZE.O: Oppenheimer cuts target price to $51 from $60

* Braze Inc BRZE.O: TD Cowen cuts target price to $45 from $52

* Bread Financial Holdings Inc BFH.N: Jefferies cuts target price to $50 from $55

* Celsius Holdings Inc CELH.O: Piper Sandler cuts target price to $47 from $50

* CF Industries Holdings Inc CF.N: Wells Fargo raises target price to $92 from $88

* Charles Schwab SCHW.N: Deutsche Bank cuts target price to $77 from $88

* Church & Dwight Co Inc CHD.N: Piper Sandler initiates with overweight rating; PT $120

* Church & Dwight Co., Inc. CHD.N: Wells Fargo raises target price to $113 from $108

* Cibus Inc CBUS.O: Alliance Global Partners cuts target price to $23.50 from $25

* Cogent Biosciences Inc COGT.O: Citigroup raises target price to $15 from $13

* Colgate-Palmolive Co CL.N: Piper Sandler initiates with overweight rating; target $121

* Columbia Banking System Inc COLB.O: Wedbush raises target price to $31 from $28

* Columbia Banking System Inc COLB.O: Wedbush raises to outperform from neutral

* Comerica Inc CMA.N: Wedbush adds stock to its best ideas list

* Comerica Inc CMA.N: Wedbush raises target price to $75 from $52

* Comerica Inc CMA.N: Wedbush raises to outperform from neutral

* Compass Inc. COMP.N: Oppenheimer raises target price to $8 from $6

* Conagra Brands Inc CAG.N: Jefferies raises target price to $30 from $27

* Constellation Brands Inc STZ.N: Barclays raises target price to $309 from $295

* Constellation Energy CEG.O: Barclays raises target price to $280 from $211

* Constellation Energy Corp CEG.O: BMO raises target price to $278 from $246

* Constellation Energy Corp CEG.O: UBS raises target price to $307 from $230

* Corbus Pharmaceuticals Holdings Inc CRBP.O: Mizuho cuts target price to $42 from $74

* Corning GLW.N: Mizuho raises target price to $51 from $47

* Costco Wholesale Corp COST.O: Raymond James raises target price to $980 from $880

* Costco Wholesale Corp COST.O: Truist Securities cuts to hold from buy

* Coty Inc. COTY.N: Wells Fargo cuts target price to $10 from $11

* Crowdstrike CRWD.O: Jefferies raises target price to $345 from $315

* Cullen/Frost Bankers Inc CFR.N: Wedbush cuts target price to $123 from $124

* Customers Bancorp Inc CUBI.N: Wedbush cuts target price to $53 from $79

* Customers Bancorp Inc CUBI.N: Wedbush cuts to neutral from outperform

* CVB Financial Corp CVBF.O: Wedbush cuts target price to $20 from $21

* Dayforce Inc DAY.N: Keybanc initiates coverage with overweight rating; target price $70

* Doordash DASH.O: Raymond James resumes coverage with outperform rating; target $155

* Edgewell Personal Care Company EPC.N: Wells Fargo cuts target price to $41 from $43

* EOG Resources Inc EOG.N: JP Morgan raises target price to $139 from $135

* Equinix Inc EQIX.O: CFRA cuts to hold from buy

* Equity Residential EQR.N: BofA Global Research raises price objective to $82 from $78

* Essex Property Trust Inc ESS.N: BofA Global Research raises price objective to $321 from $307

* Fibrobiologics Inc FBLG.O: Maxim Group initiates coverage with buy rating; target price $12

* First Citizens Bancshares FCNCA.O: Wedbush cuts target price to $2150 from $2450

* First Citizens Bancshares FCNCA.O: Wedbush cuts to neutral from outperform

* First Citizens Bancshares FCNCA.O: Wedbush removes stock from its best ideas list

* First Horizon Corp FHN.N: Wedbush cuts target price to $17 from $20

* First Horizon Corp FHN.N: Wedbush cuts to neutral from outperform

* First Horizon Corp FHN.N: Wedbush removes stock from its best ideas list

* Foghorn Therapeutics FHTX.O: Morgan Stanley raises target price to $9.00 from $6.00

* Fox Corp FOXA.O: Guggenheim raises target price to $45 from $44

* GE Vernova Inc GEV.N: Guggenheim initiates coverage with buy rating; target price $300

* Hanmi Financial Corp HAFC.O: Wedbush cuts target price to $21 from $22

* Hershey HSY.N: Barclays cuts target price to $202 from $204

* Hewlett Packard Enterprise Co HPE.N: Citigroup resumes with neutral rating; target $20

* Home Depot Inc HD.N: Oppenheimer raises target price to $400 from $345

* Hut 8 Corp HUT.O: Needham raises target price to $16.50 from $15

* Ideaya Biosciences Inc IDYA.O: Wedbush cuts target price to $52 from $54

* Insperity Inc NSP.N: William Blair cuts to market perform rating

* Instacart CART.O: Morgan Stanley cuts target price to $41.00 from $45.00

* Invitation Homes Inc INVH.N: BofA Global Research cuts price objective to $37 from $39

* Juniper Networks Inc JNPR.N: Citigroup resumes coverage with neutral rating; target price $40

* Kenvue Inc KVUE.N: Jefferies initiates coverage with buy rating; target price $27

* Kenvue Inc KVUE.N: RBC cuts to sector perform from outperform

* Keurig DR Pepper Inc. KDP.O: Wells Fargo raises target price to $43 from $41

* Keycorp KEY.N: Wedbush raises target price to $18 from $17

* Kimberly-Clark Corporation KMB.N: Wells Fargo raises target price to $140 from $134

* Lamb Weston Holdings Inc LW.N: TD Cowen raises target price to $65 from $61

* Lennar Corp LEN.N: Citigroup raises target price to $196 from $164

* Leonardo DRS Inc DRS.O: BofA Global Research raises price objective to $30 from $26

* Light & Wonder Inc LNW.O: JP Morgan cuts target price to $103 from $111

* Lipocine Inc LPCN.O: Alliance Global Partners initiates with buy rating; target $10

* Lowe's Companies Inc LOW.N: Oppenheimer raises target price to $305 from $230

* Lowe's Companies Inc LOW.N: Oppenheimer raises to outperform from perform

* Lowe's Cos. LOW.N: Oppenheimer raises target price to $305 from $230

* Lowe's Cos. LOW.N: Oppenheimer raises to outperform from perform

* Lyft Inc LYFT.O: Raymond James resumes coverage with market perform rating

* M&T Bank Corp MTB.N: Wedbush raises target price to $210 from $208

* Maplebear Inc CART.O: Raymond James initiates coverage with market perform rating

* McKesson Corp MCK.N: Baird cuts target price to $531 from $603

* McKesson Corp MCK.N: Baird cuts to neutral

* Modine Manufacturing Co MOD.N: D.A. Davidson raises target price to $155 from $140

* Molson Coors Beverage Company TAP.N: Wells Fargo cuts target price to $52 from $54

* Mosaic Co MOS.N: Wells Fargo cuts target price to $27 from $29

* National Health Investors NHI.N: BofA Global Research initiates with buy rating

* National Health Investors NHI.N: BofA Global Research initiates with price objective $92

* Newell Brands Inc. NWL.O: Wells Fargo cuts target price to $8 from $9

* Okta Inc OKTA.O: Jefferies cuts target price to $85 from $100

* P&G PG.N: Piper Sandler initiates coverage with neutral rating; target price $174

* Pacific Premier Bancorp Inc PPBI.O: Wedbush cuts target price to $27 from $28

* Pacira Biosciences Inc PCRX.O: Jefferies raises target price to $18 from $15

* Pfizer PFE.N: Guggenheim raises target price to $36 from $35

* Pinterest PINS.N: Oppenheimer initiates coverage With Outperform rating; target $45

* Prestige Consumer Healthcare PBH.N: Jefferies assumes with hold vs buy rating; PT $76 vs $70

* Procore Technologies PCOR.N: Baird initiates coverage with outperform rating; PT $73

* Prosperity Bancshares Inc PB.N: Wedbush raises target price to $90 from $75

* Prosperity Bancshares Inc PB.N: Wedbush raises to outperform from neutral

* Protagonist Therapeutics Inc PTGX.O: TD Cowen initiates coverage with buy rating; PT $65

* Public Service Enterprise Group Inc PEG.N: UBS raises target price to $94 from $87

* Regeneron Pharmaceuticals Inc REGN.O: Leerink Partners cuts target price to $1077 from $1175

* Regeneron Pharmaceuticals Inc REGN.O: Leerink Partners cuts to market perform from outperform

* Regeneron Pharmaceuticals Inc REGN.O: RBC cuts target price to $1,252 from $1,282

* Regions Financial RF.N: Wedbush raises target price to $28 from $23

* Regions Financial RF.N: Wedbush raises to outperform from neutral

* Reinsurance Group of America Inc RGA.N: Raymond James raises target to $250 from $228

* Replimune Group Inc REPL.O: JP Morgan raises target price to $17 from $14

* Ryan Specialty Holdings Inc RYAN.N: BMO raises target price to $75 from $65

* Ryan Specialty Holdings Inc RYAN.N: BMO raises to outperform from market perform

* Sable Offshore Corp SOC.N: Benchmark raises target price to $37 from $24

* Salesforce Inc CRM.N: Piper Sandler raises target price to $325 from $268

* Salesforce Inc CRM.N: Piper Sandler raises to overweight from neutral

* Sallie Mae SLM.O: Wedbush cuts target price to $26 from $29

* Shake Shack Inc SHAK.N: JP Morgan cuts target price to $102 from $105

* Sharkninja Inc SN.N: Canaccord Genuity raises target price to $126 from $105

* Sirius XM Holdings Inc SIRI.O: Morgan Stanley resumes with underweight rating; PT $23

* Snowflake Inc SNOW.N: UBS cuts target price to $125 from $155

* Spectrum Brands Holdings, Inc. SPB.N: Wells Fargo raises target price to $95 from $90

* Starbucks SBUX.O: Jefferies cuts target price to $76 from $80

* Starbucks SBUX.O: Jefferies cuts to underperform from hold

* Talen Energy Corp. TLN.O: Oppenheimer raises target price to $210 from $167

* Texas Capital Bancshares Inc TCBI.O: Wedbush raises target price to $77 from $70

* the Clorox Company CLX.N: Wells Fargo raises target price to $155 from $135

* the Estee Lauder Companies Inc. EL.N: Wells Fargo cuts target price to $105 from $117

* Tradeweb Markets Inc TW.O: Jefferies raises target price to $118 from $109

* Tripadvisor Inc TRIP.O: Citigroup cuts target price to $16 from $20

* Triumph Group Inc TGI.N: BofA Global Research cuts to underperform from buy

* Triumph Group Inc TGI.N: BofA Global Research cuts price objective to $12 from $17

* Uber UBER.N: Raymond James resumes coverage with strong buy rating; price target $90

* Union Pacific Corp UNP.N: BofA Global Research cuts price objective to $270 from $273

* Valley National Bancorp VLY.O: Wedbush raises target price to $10 from $9

* Verizon VZ.N: Raymond James raises target price to $48 from $44

* Vistra Corp VST.N: Jefferies raises target price to $137 from $99

* Walmart WMT.N: Truist Securities raises target price to $89 from $76

* Walmart WMT.N: Truist Securities raises to buy from hold

* Western Alliance Bancorp WAL.N: Wedbush adds stock to its best ideas list

* Western Alliance Bancorp WAL.N: Wedbush raises target price to $105 from $90

* Zevra Therapeutics Inc ZVRA.O: Canaccord Genuity raises target price to $25 from $22


(Compiled by Bengaluru Newsroom)

</body></html>

دستبرداری: XM Group کے ادارے ہماری آن لائن تجارت کی سہولت تک صرف عملدرآمد کی خدمت اور رسائی مہیا کرتے ہیں، کسی شخص کو ویب سائٹ پر یا اس کے ذریعے دستیاب کانٹینٹ کو دیکھنے اور/یا استعمال کرنے کی اجازت دیتا ہے، اس پر تبدیل یا توسیع کا ارادہ نہیں ہے ، اور نہ ہی یہ تبدیل ہوتا ہے یا اس پر وسعت کریں۔ اس طرح کی رسائی اور استعمال ہمیشہ مشروط ہوتا ہے: (i) شرائط و ضوابط؛ (ii) خطرہ انتباہات؛ اور (iii) مکمل دستبرداری۔ لہذا اس طرح کے مواد کو عام معلومات سے زیادہ کے طور پر فراہم کیا جاتا ہے۔ خاص طور پر، براہ کرم آگاہ رہیں کہ ہماری آن لائن تجارت کی سہولت کے مندرجات نہ تو کوئی درخواست ہے، اور نہ ہی فنانشل مارکیٹ میں کوئی لین دین داخل کرنے کی پیش کش ہے۔ کسی بھی فنانشل مارکیٹ میں تجارت میں آپ کے سرمائے کے لئے ایک خاص سطح کا خطرہ ہوتا ہے۔

ہماری آن لائن تجارتی سہولت پر شائع ہونے والے تمام مٹیریل کا مقصد صرف تعلیمی/معلوماتی مقاصد کے لئے ہے، اور اس میں شامل نہیں ہے — اور نہ ہی اسے فنانشل، سرمایہ کاری ٹیکس یا تجارتی مشورے اور سفارشات؛ یا ہماری تجارتی قیمتوں کا ریکارڈ؛ یا کسی بھی فنانشل انسٹرومنٹ میں لین دین کی پیشکش؛ یا اسکے لئے مانگ؛ یا غیر متنازعہ مالی تشہیرات پر مشتمل سمجھا جانا چاہئے۔

کوئی تھرڈ پارٹی کانٹینٹ، نیز XM کے ذریعہ تیار کردہ کانٹینٹ، جیسے: راۓ، خبریں، تحقیق، تجزیہ، قیمتیں اور دیگر معلومات یا اس ویب سائٹ پر مشتمل تھرڈ پارٹی کے سائٹس کے لنکس کو "جیسے ہے" کی بنیاد پر فراہم کیا جاتا ہے، عام مارکیٹ کی تفسیر کے طور پر، اور سرمایہ کاری کے مشورے کو تشکیل نہ دیں۔ اس حد تک کہ کسی بھی کانٹینٹ کو سرمایہ کاری کی تحقیقات کے طور پر سمجھا جاتا ہے، آپ کو نوٹ کرنا اور قبول کرنا ہوگا کہ یہ کانٹینٹ سرمایہ کاری کی تحقیق کی آزادی کو فروغ دینے کے لئے ڈیزائن کردہ قانونی تقاضوں کے مطابق نہیں ہے اور تیار نہیں کیا گیا ہے، اسی طرح، اس پر غور کیا جائے گا بطور متعلقہ قوانین اور ضوابط کے تحت مارکیٹنگ مواصلات۔ براہ کرم یقینی بنائیں کہ آپ غیر آزاد سرمایہ کاری سے متعلق ہماری اطلاع کو پڑھ اور سمجھ چکے ہیں۔ مذکورہ بالا معلومات کے بارے میں تحقیق اور رسک وارننگ ، جس تک رسائی یہاں حاصل کی جا سکتی ہے۔

خطرے کی انتباہ: آپکا سرمایہ خطرے پر ہے۔ ہو سکتا ہے کہ لیورج پروڈکٹ سب کیلیے موزوں نہ ہوں۔ براہ کرم ہمارے مکمل رسک ڈسکلوژر کو پڑھیے۔